Athenex
Athenex is focused on the development and commercialization of therapies for cancer and immunomodulatory diseases.
Launch date
Employees
Market cap
$149m
Enterprise valuation
$261m (Public information from Aug 2023)
Share price
$0.0152 ATNX
Buffalo New York (HQ)
Authorizing premium user...